SCHEMBL4948620

SCHEMBL4948620

O=C1CCC(C(O)O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8065608 0.84 ESR2 (0.37)
SCHEMBL27656105 0.81
SCHEMBL2872563 0.76 THRB (0.39)
SCHEMBL1823080 0.75
SCHEMBL6520242 0.75
SCHEMBL21996075 0.75
SCHEMBL14628363 0.75
SCHEMBL27985747 0.75 THRB (0.36)
SCHEMBL52628 0.75 THRB (0.49)
Formic Acid SCHEMBL27656008 0.74 THRB (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1284741-B1 3'-OR 2'-HYDROXYMETHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS PHARMASSET INC (US) 2008-11-19 EP disclosed
EP-1964569-A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections Pharmasset, Inc. (US) 2008-09-03 EP disclosed
US-7094770-B2 3′-or 2′-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections PHARMASSET, LTD. (BB) 2006-08-22 US disclosed
US-20020055483-A1 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatites virus infections PHARMASSET, INC. 2002-05-09 US disclosed